Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 8Other 5Gynecologic 4Endocrine 3Tumor-Agnostic 1Plasma cell 1NET 1Myeloid 1Head & Neck 1Gastrointestinal 1

Conditions

Neuroendocrine Tumors 1Multiple Endocrine Neoplasia Type 1 1Growth Hormone-Secreting Pituitary Adenoma 1Feeding Behavior 1Cardiovascular Diseases 1

Interventions

Everolimus 61lutetium Lu 177 dotatate 53Magnetic Resonance Spectroscopy 39pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 25lanreotide 24gallium Ga 68 dotatate 24cabozantinib 22pasireotide 21lenvatinib 203-Iodobenzylguanidine 20Etoposide 19Sunitinib 18Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18surufatinib 16Bevacizumab 16trametinib 15dabrafenib 15Sorafenib 14Doxorubicin 14Ipilimumab 13Thyrotropin Alfa 12Surgical Procedures, Operative 12Injections 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Diet, Mediterranean × Endocrine × Clear all
NCT06949891 2025-04-29

KETOACRO

Erasmus Medical Center

Phase NA Recruiting
60 enrolled
Endocrine

Growth Hormone-Secreting Pituitary Adenoma

NCT03592940 2018-07-19

NetNutr

Federico II University

Completed
100 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT01852721 2013-09-06

Effects of the Mediterranean Diet on Cardiovascular Risk Profile in Men and Women (ALIMED)-Part 2

Laval University

Phase NA Completed
123 enrolled
Endocrine

Cardiovascular Diseases, Feeding Behavior, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡